G730-0350 Screening compound: (3-methyl-1,2,3,4-tetrahydropyrido[1,2-a][1,3]benzimidazol-7-yl)(4-phenylpiperazino)methanone

G730-0350 Screening compound: (3-methyl-1,2,3,4-tetrahydropyrido[1,2-a][1,3]benzimidazol-7-yl)(4-phenylpiperazino)methanone
G730-0350 Screening compound: (3-methyl-1,2,3,4-tetrahydropyrido[1,2-a][1,3]benzimidazol-7-yl)(4-phenylpiperazino)methanone alternative view

Chemical Structure Depiction of ChemDiv screening compound G730-0350
(3-methyl-1,2,3,4-tetrahydropyrido[1,2-a][1,3]benzimidazol-7-yl)(4-phenylpiperazino)methanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G730-0350

Molecular Formula

C23H26N4O (C23 H26 N4 O)

Compound Name

(3-methyl-1,2,3,4-tetrahydropyrido[1,2-a][1,3]benzimidazol-7-yl)(4-phenylpiperazino)methanone

IUPAC name

11-methyl-5-(4-phenylpiperazine-1-carbonyl)-18-diazatricyclo[7.4.0.0^{27}]trideca-2(7)358-tetraene

SMILES

CC1Cc2nc(cc(cc3)C(N(CC4)CCN4c4ccccc4)=O)c3n2CC1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

374.49

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

3.616

Distribution Coefficient, logD

3.578

Water Solubility, LogSw

-3.76

Polar Surface Area

31.348

Acid Dissociation Constant (pKa)

23.42

Base Dissociation Constant (pKb)

6.36

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

39.10

G730-0350 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with G730-0350 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G730-0350?
Check Price and Availability of G730-0350, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G730-0350 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G730-0350
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G730-0350
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G730-0350 available by request